Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2009-12-03
2011-10-04
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S092000, C546S256000, C514S602000, C514S350000
Reexamination Certificate
active
08030517
ABSTRACT:
The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.
REFERENCES:
patent: 2997368 (1961-08-01), Barent et al.
patent: 3121103 (1964-02-01), Keller et al.
patent: 3344183 (1967-09-01), Reeder et al.
patent: 3442946 (1969-05-01), Keller et al.
patent: 3534062 (1970-10-01), Wright et al.
patent: 3551427 (1970-12-01), Ott et al.
patent: 3842082 (1974-10-01), Hunziker et al.
patent: 4166452 (1979-09-01), Generales, Jr.
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 4372975 (1983-02-01), Mouzin et al.
patent: 4954518 (1990-09-01), Takano et al.
patent: 4992091 (1991-02-01), Vinogradoff et al.
patent: 4997940 (1991-03-01), Vinogradoff et al.
patent: 5021591 (1991-06-01), Vinogradoff et al.
patent: 5071468 (1991-12-01), Astles et al.
patent: 5093364 (1992-03-01), Richards et al.
patent: 5155121 (1992-10-01), Niewohner et al.
patent: 5163995 (1992-11-01), Van Heertum et al.
patent: 5185348 (1993-02-01), Niewohner et al.
patent: 5217521 (1993-06-01), Durr
patent: 5217976 (1993-06-01), Ratcliffe et al.
patent: 5236937 (1993-08-01), Bradbury et al.
patent: 5294620 (1994-03-01), Ratcliffe et al.
patent: 5338755 (1994-08-01), Wagon et al.
patent: 5481005 (1996-01-01), Wagon et al.
patent: 5541186 (1996-07-01), Breu et al.
patent: 5571775 (1996-11-01), Van Heertum et al.
patent: 5589478 (1996-12-01), Yamada et al.
patent: 5780488 (1998-07-01), Bergman et al.
patent: 5973148 (1999-10-01), Ringer et al.
patent: 6136971 (2000-10-01), Harrington et al.
patent: 6200995 (2001-03-01), De la Brouse-Elwood et al.
patent: 6297195 (2001-10-01), Gesing et al.
patent: 6297239 (2001-10-01), deSolms et al.
patent: 6316450 (2001-11-01), Bromidge et al.
patent: 6403607 (2002-06-01), Hidaka et al.
patent: 6432624 (2002-08-01), Kikuchi et al.
patent: 6653332 (2003-11-01), Jaen et al.
patent: 6770648 (2004-08-01), McGee et al.
patent: 6939885 (2005-09-01), Ungashe et al.
patent: 7238717 (2007-07-01), Fleming et al.
patent: 7282502 (2007-10-01), Fleming et al.
patent: 7582661 (2009-09-01), Ugashe et al.
patent: 2002/0009116 (2002-01-01), Kobayashi et al.
patent: 2002/0012680 (2002-01-01), Patel et al.
patent: 2002/0013314 (2002-01-01), Zhu et al.
patent: 2002/0037905 (2002-03-01), Dahl et al.
patent: 2002/0037928 (2002-03-01), Jaen et al.
patent: 2002/0052363 (2002-05-01), Dinsmore et al.
patent: 2002/0065303 (2002-05-01), Zhu et al.
patent: 2002/0072530 (2002-06-01), Zhu et al.
patent: 2002/0103202 (2002-08-01), Pinto et al.
patent: 2003/0060460 (2003-03-01), Ohuchida et al.
patent: 2003/0139390 (2003-07-01), McGee et al.
patent: 2004/0167113 (2004-08-01), Ugashe et al.
patent: 2004/0171654 (2004-09-01), Ugashe et al.
patent: 2005/0137193 (2005-06-01), Ungashe et al.
patent: 561703 (1975-03-01), None
patent: 585222 (1977-01-01), None
patent: 2022187 (1970-11-01), None
patent: 2257443 (1973-05-01), None
patent: 3544409 (1986-10-01), None
patent: 3825041 (1990-02-01), None
patent: 0015214 (1980-09-01), None
patent: 0526348 (1993-02-01), None
patent: 0556673 (1993-08-01), None
patent: 0613894 (1994-09-01), None
patent: 884847 (1961-12-01), None
patent: 1332697 (1973-10-01), None
patent: 6-113060 (1994-04-01), None
patent: 145145 (1994-05-01), None
patent: 89412 (2001-04-01), None
patent: 4364168 (2009-08-01), None
patent: WO 93/03013 (1993-02-01), None
patent: WO 94/20142 (1994-09-01), None
patent: WO 95/33462 (1995-12-01), None
patent: WO 96/08483 (1996-03-01), None
patent: WO 97/28129 (1997-08-01), None
patent: WO 98/11218 (1998-03-01), None
patent: WO 98/28270 (1998-07-01), None
patent: WO 98/50029 (1998-11-01), None
patent: WO 99/17777 (1999-04-01), None
patent: WO 99/32433 (1999-07-01), None
patent: WO 99/38845 (1999-08-01), None
patent: WO 99/42465 (1999-08-01), None
patent: WO 99/55324 (1999-11-01), None
patent: WO 99/55663 (1999-11-01), None
patent: WO 00/05214 (2000-02-01), None
patent: WO 00/62778 (2000-10-01), None
patent: WO 01/00579 (2001-01-01), None
patent: WO 01/09097 (2001-02-01), None
patent: WO 01/17971 (2001-03-01), None
patent: WO 01/19788 (2001-03-01), None
patent: WO 01/19798 (2001-03-01), None
patent: WO 01/32646 (2001-05-01), None
patent: WO 01/56607 (2001-08-01), None
patent: WO 01/56989 (2001-08-01), None
patent: WO 01/57003 (2001-08-01), None
patent: WO 01/57020 (2001-08-01), None
patent: WO 01/60319 (2001-08-01), None
patent: WO 01/60369 (2001-08-01), None
patent: WO 02/00633 (2002-01-01), None
patent: WO 02/18326 (2002-03-01), None
patent: WO 02/30358 (2002-04-01), None
patent: WO 02/054867 (2002-07-01), None
patent: WO 02/055501 (2002-07-01), None
patent: WO 02/059080 (2002-08-01), None
patent: WO 03/099773 (2003-12-01), None
patent: WO 2004/046092 (2004-06-01), None
patent: WO 2004/058164 (2004-07-01), None
patent: WO 2004/085384 (2004-10-01), None
patent: WO 2004/099127 (2004-11-01), None
patent: WO 2005/004810 (2005-01-01), None
patent: WO 2005/112925 (2005-12-01), None
patent: WO 2006/076644 (2006-07-01), None
patent: WO 2007/014054 (2007-02-01), None
Street, Jonathan D. et al., “Cyclising Nucleophilic Addition to Azinium Systems, Part 2. Reactions of 3-acylpyridinium hydrazones,”Journal of Chemical Research, Synopses, vol. 5 (1987), pp. 154-155 (abstract only).
Street, Jonathan D. et al., “Cyclising Nucleophilic Addition to Azinium Systems. Part 2. Reactions of 3-Acylpyridinium Hydrazones,”Journal of Chemical Research(S) (1987), pp. 154-155.
Danhardt, Gerd et al., “COX-1/COX-2 Inhibitors Based on the Methanone Moiety,”European Journal of Medicinal Chemistry, vol. 37, (Feb. 2002), pp. 147-161.
Supplementary European Search Report issued Feb. 1, 2006 in European Application No. EP 03755422.7, which corresponds to U.S. Appl. Nos. 10/443,155 and 12/288,075.
International Search Report issued on Oct. 20, 2003 in PCT Application No. PCT/US03/16090, which corresponds to U.S. Appl. Nos. 11/391,633 and 12/288,075.
Haste, Sigrid et al., “Chemokine Receptor Inhibition by AMD3100 is Strictly Confined to CXCR4,”FEBS Letters, vol. 527, (Sep. 11, 2002), pp. 255-262.
Street, Jonathan D. et al., “Cyclising Nucleophilic Addition to Azinium Systems,”Journal of Chemical Research Synopses, No. 5, (1987) pp. 154-155. CA 108:37599 (1988).
West, Anthony R., “Solid State Chemistry and Its Applications,” John Wiley & Sons, New York, (1988), pp. 358 & 365.
Vippagunta, S.R. et al., “Crystalline Solids,”Advanced Drug Delivery Reviews, vol. 48, No. 1, (May 2001), pp. 3-26.
Kelsall, Brian L. et al., “Involvement of Intestinal Dendritic Cells in Oral Tolerance, Immunity to Pathogens, and Inflammatory Bowel Disease,”Immunological Reviews, vol. 206, Issue 1, (Aug. 2005), pp. 132-148.
Yu, Cheng-Rong et al. “CCR9A and CCR9B: Two Receptors for the Chemokine CCL25/TECK/Ckβ-15 That Differ in Their Sensitivities to Ligand,”Journal of Immunology, vol. 164, (2000), pp. 1293-1305.
Hatoum, O.A. et al., “The Intestinal Microvasculature As a Therapeutic Target in Inflammatory Bowel Disease,”Annals of the New York Academy of Sciences., vol. 1072 ,(2006), pp. 78-97.
Silvestri et al. “Anti-HIV-1 NNRT Agents: Acylamino Pyrryl Aryl Sulfones (APASs) as Truncated Analogues of Tricyclic PBTDs,”Medicinal Chemistry Research, vol. 11, No. 4, (2002), pp. 195-218. CA 138: 187588 (2002).
International Search Report issued in PCT Application No. PCT/US03/16090, which corresponds to U.S. Appl. No. 11/391,633, Oct. 20, 2003.
Silvestri et al. Medicinal Chemistry Research, 11(4): 195-218, 2002. CA 138:187588, 2002.
Hatoum et al., Ann. N.Y. Acad. Sci. 1072: 78-97, 2006.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta et al., Advanced Drug Delivery Reviews 48:
Chen B. Shaowu
Fleming Paul E.
Harriman Geraldine C. B.
Shi Zhan
Balasubramanian Venkataraman
Millennium Pharmaceuticals Inc.
LandOfFree
CCR9 inhibitors and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CCR9 inhibitors and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CCR9 inhibitors and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282871